Gender influences treatment and survival in colorectal cancer surgery

Diseases of the Colon and Rectum

Volumn 52, Issue 12, 2009, Pages 1982-1991

  Carter Paulson, E ^a   Wirtalla, Christopher ^a   Armstrong, Katrina ^a   Mahmoud, Najjia N ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Colon cancer; Disparities; Gender; Outcomes; Rectal cancer; Treatment

Indexed keywords

AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; CORRELATION ANALYSIS; DATA BASE; DEMOGRAPHY; FEMALE; GENDER; HOSPITAL; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICARE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECTUM CANCER; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME; UNITED STATES; AGE; COLON TUMOR; DISEASE FREE SURVIVAL; HEALTH CARE DISPARITY; MORTALITY; RECTUM TUMOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; RECTAL NEOPLASMS; SEER PROGRAM; SEX FACTORS;

EID: 73949143543     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181beb42a     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. McArdle CS, McMillan DC, Hole DJ. Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 2003;90:711-715
3. Ratto C, Sofo L, Ippoliti M, et al. Prognostic factors in colorectalcancer. Literature review for clinical application. Dis Colon Rectum 1998;41:1033-1049
4. Wichmann MW, Muller C, Hornung HM, et al. Gender differences in long-term survival of patients with colorectal cancer. Br J Surg 2001;88:1092-1098
5. Gatta G, Ciccolallo L, Capocaccia R, et al. Differences in colorectal cancer survival between European and US populations:the importance of sub-site and morphology. Eur J Cancer 2003; 39:2214-2222
6. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEERMedicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002; 40:3-18.
7. SEER - About the SEER Program. Available at: http://seer.cancer.gov/ about/. Accessed March 28, 2008.
8. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46:1075-1079
9. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383
10. Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002;346:1138-1144
11. Billingsley KG, Morris AM, Dominitz JA, et al. Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationship. Arch Surg 2007;142:23-31.
12. Schrag D, Cramer LD, Bach PB, et al. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA 2000;284:3028-3035
13. Bach PB, Cramer LD, Schrag D, et al. The influence of hospital volume on survival after resection for lung cancer.NEngl J Med 2001;345:181-188
14. Gilligan MA, Neuner J, Sparapani R, et al. Surgeon characteristics and variations in treatment for early-stage breast cancer. Arch Surg 2007;142:17-22.
15. Schrag D, Panageas KS, Riedel E, et al. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol 2003;83:68-78.
16. Virnig BA, Warren JL, Cooper GS, et al. Studying radiation therapy using SEER-Medicare-linked data. Med Care 2002;40: 49-54.
17. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 2002;40: 55-61.
18. Godwin JD, Brown CC. Some Prognostic factors in survival of patients with cancer of the colon and rectum. J Chronic Dis 1975;28:441-454
19. Petrek JA, Sandberg WA, Bean PK. The role of gender and other factors in the prognosis of young patients with colorectal cancer. Cancer 1985;56:952-955
20. Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 2004;240:260-268
21. Bufalari A, Giustozzi G, Burattini MF, et al. Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors. J Surg Oncol 2006;93:173-180
22. Wolters U, Stutzer H, Isenberg J. Gender related survival in colorectal cancer. Anticancer Res 1996;16:1281-1289
23. Newland RC, Dent OF, Lyttle MN, et al. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994;73:2076-2082
24. Park YJ, Park KJ, Park JG, et al. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 1999;23:721-726
25. Park YJ, Youk EG, Choi HS, et al. Experience of 1446 rectal cancer patients in Korea and analysis of prognostic factors. Int J Colorectal Dis 1999;14:101-106
26. Coleman MP, Babb P, Damiecki P, et al. Cancer survival trends in England and Wales, 1971-1995: deprivations and NHS region. The Stationary Office: London, 1999.
27. Harling H, Bulow S, Kronborg O, et al. Survival of rectal cancer patients in Denmark during 1994-1999. Colorectal Dis 2004;6: 153-157 (Pubitemid 38660633)
28. McMahon LF, Jr, Wolfe RA, Huang S, et al. Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care 1999;37:712-717
29. Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med 2004;19:332-338
30. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004;100:2093-2103
31. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer-screening tests and associated health behaviors. Am J Prev Med 2001;21: 132-137
32. Verschueren RC, Mulder NH, Van Loon AJ, et al. The anatomical substrate for a difference in surgical approach to rectal cancer in male and female patients. Anticancer Res 1997;17:637-641
33. Gennari L, Doci R, Rossetti C. Prognostic factors in colorectal cancer. Hepatogastroenterology 2000;47:310-314
34. Jeyarajah S, Sutton CD, Miller AS, et al. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Colorectal Dis 2007;9:808-815
35. McMillan DC, Wotherspoon HA, Fearon KC, et al. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 1995;170:319-322
36. Wichmann MW, Zellweger R, DeMaso CM, et al. Mechanism of immunosuppression in males following trauma-hemorrhage. Critical role of testosterone. Arch Surg 1996;131:1186-1191
37. Wichmann MW, Ayala A, Chaudry IH. Male sex steroids are responsible for depressing macrophage immune function after trauma-hemorrhage. Am J Physiol 1997;273:C1335-40.